HBV vaccination status in patients with end stage pulmonary disease evaluated for lung transplantation

Background: In times of limited donor resources, anti-HBc positive organs can be accepted for lung transplantation in order to increase the number of donors. Transplant recipients should be vaccinated against hepatitis B during transplant evaluation to prevent HBV infection. However, response after HBV vaccination has not been evaluated in patients with end stage pulmonary disease. Methods: Anti-HBs titers of anti-HBc negative patients with end stage pulmonary disease evaluated for lung transplantation were analyzed with the Architect® system (Abbott, Germany). Responders, partial responders, or non-responders a…